The learning curve for transoral incisionless fundoplication
- PMID: 34790546
- PMCID: PMC8589558
- DOI: 10.1055/a-1547-6599
The learning curve for transoral incisionless fundoplication
Abstract
Background and study aims Transoral incisionless fundoplication (TIF) is a safe and effective minimally invasive endoscopic technique for treating gastroesophageal reflux disease (GERD). The learning curve for this technique has not been reported. We studied the learning curve for TIF when performed by a gastroenterologist by identifying the threshold number of procedures needed to achieve consistent technical success or proficiency (consistent creation of TIF valve ≥ 270 degrees in circumference, ≥ 2 cm long) and efficiency after didactic, hands-on and case observation experience. Patients and methods We analyzed prospectively collected data from patients who had TIF performed by a single therapeutic endoscopist within 17 months after basic training. We determined thresholds for procedural learning using cumulative sum of means (CUSUM) analysis to detect changes in achievement rates over time. We used breakpoint analysis to calculate procedure metrics related to proficiency and efficiency. Results A total of 69 patients had 72 TIFs. The most common indications were refractory GERD (44.7 %) and proton pump inhbitor intolerance (23.6 %). Proficiency was achieved at the 18 th to 20 th procedure. The maximum efficiency for performing a plication was achieved after the 26 th procedure, when mean time per plication decreased to 2.7 from 5.1 minutes (P < 0.0001). TIF procedures time varied until the 44 th procedure, after which it decreased significantly from 53.7 minutes to 39.4 minutes (P < 0.0001). Conclusions TIF can be safely, successfully, and efficiently performed in the endoscopy suite by a therapeutic endoscopist. The TIF learning curve is steep but proficiency can be achieved after a basic training experience and 18 to 20 independently performed procedures.
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Conflict of interest statement
Competing interests Dr. Ngamruengphong is a consultant for Boston Scientific. Dr. Kumbhari is a consultant for Medtronic, Pentax Medical (USA), Boston Scientific, FujiFilm, Apollo Endosurgery, and received research support from Erbe USA, and Apollo Endosurgery. Dr. Khashab is a consultant for Boston Scientific, Medtronic, Olympus, GI Supply, and Triton. Dr. Murray is a consultant for Endogastric Solutions. PJ is a consultant for Endogastric solutions, Ethicon/J&J, and Olympus. Dr. Ihde is a consultant for Endogastric solutions, and Microline Medical. Dr. Chang is a consultant for Apollo Endosurgery, Cook, Erbe USA, Endogastric solutions, Mauna Kea, Mederi, Medtronic, Olympus, Ovesco and Pentax Medical (USA). Dr. Thosani is a consultant for Boston Scientific, Medtronic, Pentax Medical (USA), received research support from Pentax Medical (USA), royalties from UpToDate, and is on the advisory board of ColubrisMX. Dr. Canto received research grants from Endogastric solutions and Pentax Medical (USA), and royalties from UpToDate.
Figures
References
-
- Hakansson B, Montgomery M, Cadiere G B et al. Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD. Aliment Pharmacol Ther. 2015;42:1261–1270. - PubMed
LinkOut - more resources
Full Text Sources
